Algert Global’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Sell |
18,693
-26,850
| -59% | -$375K | 0.01% | 1061 |
|
|
2025
Q1 | $614K | Sell |
45,543
-50,850
| -53% | -$686K | 0.02% | 865 |
|
|
2024
Q4 | $1.85M | Sell |
96,393
-18,520
| -16% | -$355K | 0.04% | 631 |
|
|
2024
Q3 | $2.61M | Buy |
114,913
+59,420
| +107% | +$1.35M | 0.07% | 468 |
|
|
2024
Q2 | $722K | Buy |
55,493
+17,673
| +47% | +$230K | 0.02% | 772 |
|
|
2024
Q1 | $662K | Buy |
+37,820
| New | +$662K | 0.03% | 714 |
|
|
2023
Q3 | – | Sell |
-37,025
| Closed | -$881K | – | 1265 |
|
|
2023
Q2 | $881K | Sell |
37,025
-23,523
| -39% | -$560K | 0.04% | 685 |
|
|
2023
Q1 | $1.54M | Sell |
60,548
-4,705
| -7% | -$120K | 0.07% | 440 |
|
|
2022
Q4 | $1.91M | Buy |
+65,253
| New | +$1.91M | 0.11% | 314 |
|